AAAAAA

   
Results: 1-16 |
Results: 16
Anti-lymphoma effect of Naproxen and indomethacin in a patient with relapsed diffuse large B-cell lymphoma
Authors: Yoshinaga, K Teramura, M Iwabe, K Kobayashi, S Masuda, M Motoji, T Mizoguchi, H
Citation: K. Yoshinaga et al., Anti-lymphoma effect of Naproxen and indomethacin in a patient with relapsed diffuse large B-cell lymphoma, AM J HEMAT, 66(3), 2001, pp. 220-223
Successful treatment of refractory anemia by high-dose methylprednisolone associated with an increment in CD68-positive cells in bone marrow
Authors: Motomura, S Motoji, T Okutomi, K Nishikawa, T Kasajima, T Mizoguchi, H
Citation: S. Motomura et al., Successful treatment of refractory anemia by high-dose methylprednisolone associated with an increment in CD68-positive cells in bone marrow, AM J HEMAT, 66(2), 2001, pp. 80-84
Tel/MN1 fusion in a de novo acute myeloid leukaemia-M2 patient who showed strong resistance to treatment
Authors: Nakazato, H Shiozaki, H Zhou, M Nakatsu, M Motoji, T Mizoguchi, H Miyawaki, S Sato, Y
Citation: H. Nakazato et al., Tel/MN1 fusion in a de novo acute myeloid leukaemia-M2 patient who showed strong resistance to treatment, BR J HAEM, 113(4), 2001, pp. 1079-1081
Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies
Authors: Yamada, O Ichikawa, M Okamoto, T Park, C Motoji, T
Citation: O. Yamada et al., Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies, BR J HAEM, 113(1), 2001, pp. 153-160
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
Authors: Yamamoto, Y Kiyoi, H Nakano, Y Suzuki, R Kodera, Y Miyawaki, S Asou, N Kuriyama, K Yagasaki, F Shimazaki, C Akiyama, H Saito, K Nishimura, M Motoji, T Shinagawa, K Takeshita, A Saito, H Ueda, R Ohno, R Naoe, T
Citation: Y. Yamamoto et al., Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies, BLOOD, 97(8), 2001, pp. 2434-2439
Multidrug resistance of acute leukemia and a strategy to overcome it
Authors: Motoji, T Motomura, S Wang, YH
Citation: T. Motoji et al., Multidrug resistance of acute leukemia and a strategy to overcome it, INT J HEMAT, 72(4), 2000, pp. 418-424
Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): Results of an interim analysis
Authors: Okamoto, T Kanamaru, A Shimazaki, C Motoji, T Takemoto, Y Takahashi, M Fukushima, T Takeshita, A Kusumoto, S Kishimoto, Y Yorimitsu, S Tsukuda, K Uike, N Arima, N Ohno, R
Citation: T. Okamoto et al., Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): Results of an interim analysis, INT J HEMAT, 72(2), 2000, pp. 200-205
Delineation of the frequently deleted region on chromosome arm 13q in B-cell non-Hodgkin's lymphoma
Authors: Wada, M Okamura, T Okada, M Teramura, M Masuda, M Motoji, T Mizoguchi, H
Citation: M. Wada et al., Delineation of the frequently deleted region on chromosome arm 13q in B-cell non-Hodgkin's lymphoma, INT J HEMAT, 71(2), 2000, pp. 159-166
Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia
Authors: Nakano, Y Naoe, T Kiyoi, H Kitamura, K Minami, S Miyawaki, S Asou, N Kuriyama, K Kusumoto, S Shimazaki, C Akiyama, H Saito, K Nishimura, M Motoji, T Shinagawa, K Saito, H Ohno, R
Citation: Y. Nakano et al., Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia, EUR J HAEMA, 65(1), 2000, pp. 23-31
Prognostic significance of the cell cycle inhibitor p27(Kip1) in acute myeloid leukemia
Authors: Yokozawa, T Towatari, M Iida, H Takeyama, K Tanimoto, M Kiyoi, H Motoji, T Asou, N Saito, K Takeuchi, M Kobayashi, Y Miyawaki, S Kodera, Y Ohno, R Saito, H Naoe, T
Citation: T. Yokozawa et al., Prognostic significance of the cell cycle inhibitor p27(Kip1) in acute myeloid leukemia, LEUKEMIA, 14(1), 2000, pp. 28-33
Identification of a melanoma antigen, PRAME, as a BCR/ABL-inducible gene
Authors: Watari, K Tojo, A Nagamura-Inoue, T Nagamura, F Takeshita, A Fukushima, T Motoji, T Tani, K Asano, S
Citation: K. Watari et al., Identification of a melanoma antigen, PRAME, as a BCR/ABL-inducible gene, FEBS LETTER, 466(2-3), 2000, pp. 367-371
Significance of lung resistance-related protein in the clinical outcome ofacute leukaemic patients with reference to P-glycoprotein
Authors: Tsuji, K Motoji, T Sugawara, I Shiozaki, H Wang, YH Motomura, S Okada, M Yasunami, T Sano, F Takahashi, M Kawada, H Maseki, N Hoshino, S Ishida, M Mizoguchi, H
Citation: K. Tsuji et al., Significance of lung resistance-related protein in the clinical outcome ofacute leukaemic patients with reference to P-glycoprotein, BR J HAEM, 110(2), 2000, pp. 370-378
Frequent chromosome arm 13q deletion in aggressive non-Hodgkin's lymphoma
Authors: Wada, M Okamura, T Okada, M Teramura, M Masuda, M Motoji, T Mizoguchi, H
Citation: M. Wada et al., Frequent chromosome arm 13q deletion in aggressive non-Hodgkin's lymphoma, LEUKEMIA, 13(5), 1999, pp. 792-798
Selective effect of cyclosporine monotherapy for pure red cell aplasia notassociated with granular lymphocyte-proliferative disorders
Authors: Yamada, O Motoji, T Mizoguchi, H
Citation: O. Yamada et al., Selective effect of cyclosporine monotherapy for pure red cell aplasia notassociated with granular lymphocyte-proliferative disorders, BR J HAEM, 106(2), 1999, pp. 371-376
Mutation of the WT1 gene in myelodysplastic syndrome and acute myeloid leukaemia post myelodysplastic syndrome
Authors: Mori, N Okada, M Motoji, T Mizoguchi, H
Citation: N. Mori et al., Mutation of the WT1 gene in myelodysplastic syndrome and acute myeloid leukaemia post myelodysplastic syndrome, BR J HAEM, 105(3), 1999, pp. 844-845
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia
Authors: Kiyoi, H Naoe, T Nakano, Y Yokota, S Minami, S Miyawaki, S Asou, N Kuriyama, K Jinnai, I Shimazaki, C Akiyama, H Saito, K Oh, H Motoji, T Omoto, E Saito, H Ohno, R Ueda, R
Citation: H. Kiyoi et al., Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia, BLOOD, 93(9), 1999, pp. 3074-3080
Risultati: 1-16 |